# US 2012/0251508 A1 · Cytocompatible alginate gels

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0251508 A1
- Document ID: US20120251508A1
- Status: Published application
- Kind: A1
- Application number: 13/525,158
- Filed: 2012-06-15
- Published: 2012-10-04
- Earliest claimed: 2007-09-19
- Assignees: Abbott Cardiovascular Systems Inc.
- Inventors: Shubhayu Basu; Gene Michal; Florian Ludwig; Jinping Wan; John Stankus
- Web page: https://patentgrep.com/patent/US20120251508A1

## CPC

- A61L 27/52: Hydrogels or hydrocolloids
- A61L 27/20: Polysaccharides
- A61L 27/3604: {characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel}
- A61L 27/3641: {characterised by the site of application in the body (materials for artificial blood vessels A61L27/507; materials for use in artificial skin A61L27/60)}
- A61L 27/365: {Bones}
- A61L 27/3804: {characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells}
- A61L 27/3839: {characterised by the site of application in the body (materials for artificial blood vessels A61L27/507; materials for use in artificial skin A61L27/60)}
- A61P 9/00: Drugs for disorders of the cardiovascular system
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention relates to a method of making cytocompatible alginate gels and their use in the treatment of cardiomyopathy.

## Claims

### Claim 1

A method of forming a cytocompatible alginate gel, comprising:
providing an alginate;
dispersing substantially homogeneously within the alginate a plurality of cells;
dispersing substantially homogeneously within the alginate a micronized tissue construct; and
adding to the alginate a divalent metal cation to form an alginate gel.

### Claim 2 (depends on 1)

The method of claim 1, wherein the plurality of cells are selected from the group consisting of localized cardiac progenitor cells, mesenchymal stem cells, bone marrow derived mononuclear cells, adipose tissue derived stem cells, embryonic stem cells, umbilical cord blood derived stem cells, smooth muscle cells and skeletal myoblasts.

### Claim 3 (depends on 1)

The method of claim 1, wherein the micronized tissue construct are selected from the group consisting of urinary bladder matrix (UBM) and small intestinal sub-mucosa (SIS).

### Claim 4 (depends on 1)

The method of claim 1, wherein the divalent metal cation comprises Ca++.

### Claim 5 (depends on 1)

A composition comprising an alginate gel prepared by the method of claim 1.
